Reveal Insider Trading in J.C. Penney, Gilead Sciences, Chesapeake Energy, Annaly Capital Management, Endo Health Solutions, and Zynga
HONG KONG, May 14, 2013 /PRNewswire/ -- Insiderslab.com has issued insider trading reports for stock investing: J.C. Penney (NYSE: JCP), Gilead Sciences (NASDAQ: GILD), Chesapeake Energy (NYSE: CHK), Annaly Capital Management (NYSE: NLY), Endo Health Solutions (NASDAQ: ENDP), and Zynga (NASDAQ: ZNGA).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
J.C. Penney Company, Inc. (NYSE: JCP): By the end of last trading session, the shares of J.C. Penney (NYSE: JCP) rose US$0.52 (or 2.93%) to US$18.24 with 21.06 million shares exchanged hands, compared to daily average volume of 22.58 million. The trading price ranged between US$18.15 and US$19.03. The company shareholders experienced about 47% loss in the past 52 weeks. Insiderslab.com found company insiders sold his/her shares for about US$160.30 million in March. Investors may want to find out how J.C. Penney insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for JCP here.
Read Full Report: http://www.insiderslab.com/PR3/051413A/JCP/JCPenney.pdf
Gilead Sciences, Inc. (NASDAQ: GILD): By the end of last trading session, Gilead Sciences (NASDAQ: GILD) shares earned US$1.59 (or 3.01%) to US$54.47 with about 14.49 million shares exchanged hands for the session, compared to its average volume of 12.88 million shares. The share reached the 52-week high of US$56.35 recently. The stock price rose more than 110% in the past year. Insiderslab.com found company CEO, John C. Martin, sold his shares at price of US$50.17 on May 1, which was part of about US$39.97 million selling in the past three months. Investors may want to find out how Gilead Sciences insiders like CEOs, CFOs and Directors are thinking about the future of the company.
Read Full Report: http://www.insiderslab.com/PR3/051413A/GILD/GileadSciences.pdf
Chesapeake Energy Corporation (NYSE: CHK): By the end of last trading session, Chesapeake Energy (NYSE: CHK) upped US$0.41 (or 2.03%) to US$20.56 with about 19.32 million shares exchanged hands for the session, compared to its average volume of 9.62 million shares. Insiderslab.com found company insiders sold his/her shares at price of US$22.00 -- US$22.32 for about US$1.95 million. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in Chesapeake Energy are starting to buy more company shares. See insider trade report for CHK here.
Read Full Report: http://www.insiderslab.com/PR3/051413A/CHK/ChesapeakeEnergy.pdf
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Annaly Capital Management, Inc. (NYSE: NLY):
Read Full Report: http://www.insiderslab.com/PR3/051413A/NLY/AnnalyCapitalManagement.pdf
Endo Health Solutions Inc (NASDAQ: ENDP):
Read Full Report: http://www.insiderslab.com/PR3/051413A/ENDP/EndoHealthSolutions.pdf
Zynga Inc (NASDAQ: ZNGA):
Read Full Report: http://www.insiderslab.com/PR3/051413A/ZNGA/Zynga.pdf
Insider Filing Source Reference: All observations, analyses and reports are based on public information released by the U.S. Securities and Exchange Commission.
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
SOURCE Insiderslab.com; Insiders.hk
More by this Source
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.